is used to treat infertility among female patients and works by stimulating increased hormones
vital to the growth and release of mature eggs for ovulation.
Omifin is available in tablet form and marketed under the brand names Clomin, Omifin, Serophene
, and Clomiphene
Patients having difficulty becoming pregnant can take Omifin on it’s own or in conjunction with Metformin
to help them ovulate and become pregnant.
Studies show that 70% of patients who used Omifin were able to ovulate, a good majority during the first months of treatment. Of that population, 15-50% were successful in becoming pregnant.
Patients are often prescribed 50 milligrams of Omifin for 5 days beginning on the fifth day of their menstrual cycle
. In the event ovulation does not occur, dosage can be increased to 100 milligrams for 5 days the month after the previous dosage. Patients should not take Omifin after 6 treatment cycles.
Follow the dosing schedule set by your healthcare professional for best results. Patients should not take the medication for longer than prescribed. In the event of a missed dose, patients should immediately talk with their healthcare professional to determine the next steps. Do not take double doses to resume your dosing schedule.
Healthcare professionals may look into the body temperature of the patient and ovulation tests prior to prescribing Omifin.
Side effects include upset stomach
, hot flashes, pelvic fullness, headache
tenderness, or dizziness
. If these symptoms appear and persist, immediately notify your healthcare professional. The chances of a patient experiencing these side effects are low.
Change in vision, such as seeing flashes, is another possible side effect. This is more common when the patient is exposed to intense lighting. If you experience this side effect, it should go away a couple of days after treatment. In the event that it does not go away, consult your doctor.
Serious side effects include vaginal bleeding and changes in moods. Some patients may experience severe pain or swelling
in the pelvic area, diarrhea
, difficulty in breathing, chest pain
, irregular heartbeat
, and swelling of the legs
. If you experience any of these symptoms, consult your doctor immediately.
Before taking Omifin, patients should inform their healthcare professional about any history of allergies
to medications. Patients should also consult their healthcare professional about conditions such as liver
disease, vaginal bleeding, uncontrolled thyroid, and pituitary tumor before agreeing to use Omifin.
There are cases where the use of Omifin resulted in the patient having multiple births i.e. twins and triplets.
Patients are advised against engaging in activities that require mental alertness including driving because Omifin can make a person dizzy or suffer from blurred vision.
Tell your healthcare professional about all the prescription medicines they are using before taking Omifin.
Omifin has the following structural formula:
• Molecular formula of omifin is C26H28ClNO
• Chemical IUPAC Name is 2-[4-[(Z)-2-chloro-1,2-di(phenyl)ethenyl]phenoxy]-N,N-diethylethanamine
• Molecular weight is 405.9596 g/mol
• Omifin available : 50mg tablets